SCHEMBL3758593

SCHEMBL3758593

C=C(OCCCC)c1c(N2CCOCC2)sc2c1CC(C)(C)NC2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
PIK3CG P48736 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 2/20 0.37
GLA P06280 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
KMT2A Q03164 2/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765048 0.85 PIK3CD (0.42) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3755397 0.82 PIK3CA (0.47) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3764745 0.79 PIK3CD (0.52) PIK3CDPIK3CAPIK3CBPIK3CGKDM4E
SCHEMBL3761681 0.74 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGKDM4E
SCHEMBL3763208 0.72 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL3763214 0.72 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL3764678 0.71 MAP2K2 (0.49) PIK3CASMN1; SMN2KDM4EL3MBTL1LMNA
SCHEMBL3766781 0.68 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGHTT
SCHEMBL3759310 0.67 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGKDM4E
SCHEMBL3759390 0.65 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBPIK3CGHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CA 3/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.